Immunotherapy for Epstein-Barr virus-associated tumors

Leukemia & Lymphoma
Melanie A ComitoKenneth G Lucas

Abstract

Epstein-Barr Virus (EBV) is associated with a number of tumors, including lymphomas in solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients, patients with the acquired immunodeficiency syndrome (AIDS), Burkitt's lymphoma, as well as a subset of patients with nasopharyngeal carcinoma (NPC) and Hodgkin's disease (HD). The types of latent EBV infections vary in these tumors, which influences the EBV antigens expressed and ultimately the immunogenicity of tumor cells. Not all EBV associated malignancies are directly related to altered cellular immunity, as is the case with EBV induced lymphoproliferations in immunocompromised patients. Treatment strategies have ranged from restoration of normal cellular immunity, which is generally successful in SOT and HSCT patients, anti-B cell monoclonal antibodies, and conventional chemotherapy and radiation. The fact that these tumors express EBV antigens for which many individuals have high circulating levels of protective cytotoxic T lymphocytes (CTL) has lead to investigation into the applicability of adoptive transfer of EBV specific T cells. Initial success with adoptive immunotherapy for HSCT and SOT patients has lead to current studies examining the feas...Continue Reading

References

Jan 1, 1990·Molecular Carcinogenesis·Y J BignonR Plagne
Feb 23, 1989·The New England Journal of Medicine·L M WeissJ Sklar
Mar 16, 1989·The New England Journal of Medicine·N MuellerJ Vogelman
Jan 1, 1987·Advances in Cancer Research·G Tosato
Nov 15, 1974·International Journal of Cancer. Journal International Du Cancer·D P HuangG Henle
Aug 15, 1983·International Journal of Cancer. Journal International Du Cancer·S H ChanM J Simons
Mar 1, 1996·Hematological Oncology·U TirelliA Carbone
Oct 1, 1996·Hematology/oncology Clinics of North America·P A Forsyth, L M DeAngelis
Mar 21, 1998·The American Journal of Surgical Pathology·L FinnE Yunis
Jun 22, 1999·The Journal of Experimental Medicine·U KappT W Mak
Nov 25, 2000·Molecular Pathology : MP·G Niedobitek
Jan 6, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·K F IzbanS Alkan
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D ChuaM H Ng
Aug 16, 2002·British Journal of Haematology·Karin C M StraathofCliona M Rooney

❮ Previous
Next ❯

Citations

May 17, 2006·Clinical and Experimental Pharmacology & Physiology·P A MacaryX Dai
Oct 19, 2010·Journal of Oncology·Jason M God, Azizul Haque
Jun 23, 2009·International Immunopharmacology·Jiang LiYi-Xin Zeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.